3 Things to Watch on the TSX Index on Thursday

The U.S. stock futures were extremely volatile Thursday before the markets opened. However, China’s comments about working with the U.S. on trade could deliver gains rebounding from a disastrous Wednesday.  

Simple life style relaxation with Asian working business woman healthy lifestyle take it easy resting in comfort hotel or home living room having free time with peace of mind and self health balance

Image source: Getty Images

The U.S. stock futures were extremely volatile Thursday before the markets opened. 

However, China’s comments about working with the U.S. on trade could deliver gains Thursday, rebounding nicely from a disastrous Wednesday.  

Here’s what to watch on the TSX on Thursday. 

Canopy Growth delivers anything but…

Canopy Growth (TSX:WEED)(NYSE:CGC) stock dropped by 14% in pre-market trading Thursday after Canada’s largest cannabis company delivered a stinker of an earnings report Wednesday. Analysts were anything but complimentary about its slowing growth. 

The company was expected to generate $107.1 million in revenue in Q1 2020. It was only able to produce $90.5 million in sales in the quarter. On the bottom line, analysts expected it to lose $0.70 in the quarter; it actually lost $1.28 a share, 83% worse than the consensus. 

There were two positives from the quarter. 

First, revenues were up 249% from the $25.9 million last year. Second, Canopy harvested more than 40,000 kilograms of cannabis in the second quarter, a company record, 183% higher than in the fourth quarter. 

It will be interesting to see how Canopy’s stock trades on Thursday now that investors have had a chance to digest the numbers. 

Bombardier looks attractive

Bombardier (TSX:BBD.B) traded four cents lower on Wednesday, closing the day’s trading at $1.71, just 12 cents off its 52-week low. 

Citi analyst Stephen Trent characterized Bombardier’s stock as “fairly battered” but believes its long-term prognosis is good. 

“Is Bombardier done with asset sales? Only management could answer that question with certainty.

That said, Bombardier now seems well focused on its business jet and transport segments,” Trent wrote in a note to clients Wednesday. “Our forecast does not assume any asset sales, beyond what has already been announced, such as the Q400 and CRJ commercial aircraft programs.”

Trent’s target price for Bombardier is $2,75, below the average analyst price of $3.36, but still providing 61% upside based on current prices. 

Canada Goose looks ready to fly 

Talk about stocks that have taken it on the chin in 2019. 

Canada Goose (TSX:GOOS)(NYSE:GOOS) reported Q1 2020 results Wednesday. Investors weren’t happy with its results or outlook sending its stock down by more than 7.5%. 

However, if investors take a closer look at Canada Goose’s results, D.A. Davidson analyst John Morris believes the company is one of the best names out there, doing everything it can to continue growing. 

“We continue to view GOOS as well-positioned given the company’s growth initiatives, global expansion opportunities, and continued investments in IT and infrastructure to support flexibility and scalability opportunities,” Morris said in a note to clients. 

The analyst has a “buy” rating on Canada Goose with a US$48 target price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned.  

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »